ALPHA TEKNOVA, INC. Increase (Decrease) in Accrued Liabilities
ALPHA TEKNOVA, INC. (TKNO) reported Increase (Decrease) in Accrued Liabilities of -$659.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-06
- ALPHA TEKNOVA, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $113.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$772.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $472.00K, a 40.90% increase year-over-year.
- ALPHA TEKNOVA, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $753.00K, a 27.60% decline year-over-year.
- ALPHA TEKNOVA, INC. increase (decrease) in accrued liabilities for fiscal 2025 was $73.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in accrued liabilities for fiscal 2024 was -$389.00K, a 120.09% decline from fiscal 2023.
- ALPHA TEKNOVA, INC. increase (decrease) in accrued liabilities for fiscal 2023 was $1.94M, a 929.79% increase from fiscal 2022.
- ALPHA TEKNOVA, INC. increase (decrease) in accrued liabilities for fiscal 2022 was $188.00K, a 89.61% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$659.00K 10-Q · filed 2026-08-06 | -$187.00K derived: sum of 3 quarters · filed 2026-08-06 | $566.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$772.00K 10-Q · filed 2026-05-07 | -$300.00K derived: sum of 2 quarters · filed 2026-05-07 | $453.00K derived: sum of 3 quarters · filed 2026-05-07 | $318.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $472.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.23M derived: sum of 2 quarters · filed 2026-03-02 | $1.09M derived: sum of 3 quarters · filed 2026-08-06 | $73.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | $753.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $618.00K derived: sum of 2 quarters · filed 2026-08-06 | -$399.00K 10-Q · filed 2025-11-07 | -$64.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.15M 10-Q · filed 2026-08-06 | -$817.00K derived: sum of 3 quarters · filed 2026-08-06 | $223.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$1.02M 10-Q · filed 2026-05-07 | -$682.00K derived: sum of 2 quarters · filed 2026-05-07 | $358.00K derived: sum of 3 quarters · filed 2026-05-07 | $318.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $335.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.38M derived: sum of 2 quarters · filed 2026-03-02 | $1.33M derived: sum of 3 quarters · filed 2026-03-02 | -$389.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.00M derived: sum of 2 quarters · filed 2025-11-07 | -$724.00K 10-Q · filed 2025-11-07 | $397.00K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$1.76M 10-Q · filed 2025-08-08 | -$643.00K derived: sum of 3 quarters · filed 2025-08-08 | $1.41M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$1.72M 10-Q · filed 2025-05-09 | -$603.00K derived: sum of 2 quarters · filed 2025-05-09 | $1.45M derived: sum of 3 quarters · filed 2025-05-09 | $882.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $3.17M derived: sum of 2 quarters · filed 2025-03-07 | $2.61M derived: sum of 3 quarters · filed 2025-03-07 | $1.94M 10-K · filed 2025-03-07 |
| 2023-09-30 | $2.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $1.49M derived: sum of 2 quarters · filed 2024-11-08 | $815.00K 10-Q · filed 2024-11-08 | $660.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$564.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$1.23M 10-Q · filed 2024-08-13 | -$1.39M derived: sum of 3 quarters · filed 2024-08-13 | -$1.67M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$670.00K 10-Q · filed 2024-05-13 | -$825.00K derived: sum of 2 quarters · filed 2024-05-13 | -$1.11M derived: sum of 3 quarters · filed 2024-05-13 | -$1.24M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$438.00K derived: sum of 2 quarters · filed 2024-03-27 | -$574.00K derived: sum of 3 quarters · filed 2024-03-27 | $188.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | -$283.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$419.00K derived: sum of 2 quarters · filed 2023-11-13 | $343.00K 10-Q · filed 2023-11-13 | $1.60M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$136.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $626.00K 10-Q · filed 2023-08-11 | $1.88M derived: sum of 3 quarters · filed 2023-08-11 | $2.23M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $762.00K 10-Q · filed 2023-05-11 | $2.02M derived: sum of 2 quarters · filed 2023-05-11 | $2.37M derived: sum of 3 quarters · filed 2023-05-11 | $1.73M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.60M derived: sum of 2 quarters · filed 2023-03-30 | $963.00K derived: sum of 3 quarters · filed 2023-03-30 | $1.81M 10-K · filed 2023-03-30 |
| 2021-09-30 | $348.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$294.00K derived: sum of 2 quarters · filed 2022-11-14 | $553.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$642.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $205.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $847.00K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | -$886.00K 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |